Advertisement

Journal of Nanoparticle Research

, Volume 10, Supplement 1, pp 121–130 | Cite as

Combined synthesis and in situ coating of nanoparticles in the gas phase

  • Anna Lähde
  • Janne Raula
  • Esko I. Kauppinen
Research Paper

Abstract

Combined gas phase synthesis and coating of sodium chloride (NaCl) and lactose nanoparticles has been developed using an aerosol flow reactor. Nano-sized core particles were produced by the droplet-to-particle method and coated in situ by the physical vapour deposition of L-leucine vapour. The saturation of L-leucine in the reactor determined the resulting particle size and size distribution. In general, particle size increased with the addition of L-leucine and notable narrowing of the core particle size distribution was observed. In addition, homogeneous nucleation of the vapour, i.e. formation of pure L-leucine particles, was observed depending on the saturation conditions of L-leucine as well as the core particle characteristics. The effects of core particle properties, i.e. size and solid-state characteristics, on the coating process were studied by comparing the results for coated NaCl and lactose particles. During deposition, L-leucine formed a uniform coating on the surface of the core particles. The coating stabilised the nanoparticles and prevented the sintering of particles during storage.

Keywords

Aerosol Coating Gas-phase Nanoparticles Pharmaceutical Processing 

References

  1. Bodmeier R, Chen H (1990) Indomethacin polymeric nanosuspensions prepared by microfluidization. J Control Release 12:223–233CrossRefGoogle Scholar
  2. Caruso F (2001) Nanoengineering of particle surfaces. Adv Mater 13:11–22CrossRefGoogle Scholar
  3. Chen C-C, Tao C-J, Shu H-J (2000) Heterogeneous nucleation on n-butanol vapor on submicrometer charged and neutral particles of lactose and monosodium glutamate. J Colloid Interface Sci 224:11–22CrossRefGoogle Scholar
  4. Chew NYK, Shekunov BY, Tong HHY, Chow AHL, Savage C, Wu J, Chan H-K (2005) Effect of amino acids on the dispersion of disodium cromoglycate powders. J Pharm Sci 94:2289–2300CrossRefGoogle Scholar
  5. Couvreur P, Dubernet C, Puisieux F (1995) Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur J Pharm Biopharm 41:2–13Google Scholar
  6. Cruz CN, Pandis SN (1999) Condensation of organic vapors on an externally mixed aerosol population. Aerosol Sci Technol 31:392–407CrossRefGoogle Scholar
  7. Davies R, Schurr GA, Meenan P, Nelson RD, Bergna HE, Brevett CA, Goldbaum RH (1998) Engineered particle surfaces. Adv Mater 10:1264–1270CrossRefGoogle Scholar
  8. De Jaeghere F, Allémann E, Doelker E, Gurny R (2001) pH-dependent dissolving nano- and microparticles for improved peroral delivery of highly lipophilic compound in dogs. AAPS Pharm. Sci 3 (Article 8)Google Scholar
  9. Flagan RC, Lunden MM (1995) Particle structure control in nanoparticle synthesis from the vapor phase. Mater Sci Eng A204:113–124Google Scholar
  10. Flagan RC, Seinfeld JH (1988) Fundamentals of air pollution engineering. Prentice Hall, Englewood Cliffs, NJ, p 542Google Scholar
  11. Foutou GP, Kodas TT, Anderson B (2000) Coating titania aerosol particles with ZrO2, Al2O3, and SiO2/ZrO2 in gas phase process. Aerosol Sci Technol 33:557–571CrossRefGoogle Scholar
  12. Fuchs NA, Sutugin AG (1971) High-dispersed aerosols. In: Hidy GM, Brock JR (eds) Topics in current aerosol research. Pergamon Press, New York, pp 1–60Google Scholar
  13. Hinds WC (1999) Aerosol technology, 2nd edn. Wiley, New YorkGoogle Scholar
  14. Incropera FP, DeWitt DP (2002) Fundamentals of heat and mass transfer, 5th edn. Wiley, New YorkGoogle Scholar
  15. Jain S, Fotou GP, Kodas TT (1997) A theoretical study on gas-phase coating of aerosol particles. J Colloid Interface Sci 185:26–38CrossRefGoogle Scholar
  16. Kreuter J (2001) Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65–81CrossRefGoogle Scholar
  17. Lechuga-Ballesteros D, Kuo M-C (2001) Dry powder compositions having improved dispersity. WO 01/32144, 10 May 2001Google Scholar
  18. Liversidge GG, Cundy KC (1995) Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm 125:91–97CrossRefGoogle Scholar
  19. Mayville FC, Partch RE, Matijevic E (1987) Preparation of uniform spherical titania particles coated with polyurea by aerosol technique. J Colloid Interface Sci 120:135–139CrossRefGoogle Scholar
  20. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H, ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group (2005) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8CrossRefGoogle Scholar
  21. Ohring M (1992) The materials science of thin films. Academic Press, CAGoogle Scholar
  22. Parrott EI (1986) Milling. In: Lachmann L, Lieberman HA, Kanig JL (eds) The theory and practice of industrial pharmacy. Lea and Febiger, Philadelphia, PA, p 21Google Scholar
  23. Podczeck F (1999) The influence of particle size distribution and surface roughness of carrier particles on the in vitro properties of dry powder inhalations. Aerosol Sci Technol 31:301–321CrossRefGoogle Scholar
  24. Porstendörfer J, Scheibel HG, Pohl FG, Preining O, Reischl G, Wagner PE (1985) Heterogeneous nucleation of water vapour on monodispersed Ag and NaCl with diameters between 6 and 18 nm. J Aerosol Sci 4:65–79CrossRefGoogle Scholar
  25. Raula J, Kuivalainen A, Lähde A, Antopolsky M, Kansikas J, Kauppinen EI (2007) Synthesis of L-leucine nanoparticles via physical vapor deposition at varying saturation conditions. J Aerosol Sci 38:1172–1184CrossRefGoogle Scholar
  26. Raula J, Lähde A, Kauppinen EI (2008) A novel gas phase method for the combined synthesis and coating of pharmaceutical particles. Pharm Res 25:242–245CrossRefGoogle Scholar
  27. Ravi Kumar MNV (2000) Nano and microparticles as controlled drug delivery devices. J Pharm Sci 3:234–258Google Scholar
  28. Seinfeld JH, Pandis SN (1986) Atmospheric chemistry and physics: from air pollution to climate change. Wiley, New York, p 654Google Scholar
  29. Škapin S, Matijevic' E (2004) Preparation and coating of finely dispersed drugs. Loratadine and Danazol. J Colloid Interface Sci 272:90–98CrossRefGoogle Scholar
  30. Staniforth JN (2000) Carrier particles for the use in dry powder inhalers. US Patent 6,153,224Google Scholar
  31. Svec HJ, Clyde DD (1965) Vapor pressures of some alpha-amino acids. J Chem Eng Data 10:151–152CrossRefGoogle Scholar
  32. Yang J, Sliva A, Banerjee A, Dave RN, Pfeffer R (2005) Dry particle coating for improving the flowability of cohesive powders. Powder Technol 158:21–33CrossRefGoogle Scholar
  33. Zhang L, Ranade MB, Gentry JW (2004) Formation of organic coating on ultrafine silver particles using a gas-phase process. J Aerosol Sci 35:457–471CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  1. 1.NanoMaterials Group, Laboratory of PhysicsHelsinki University of TechnologyEspooFinland
  2. 2.VTT BiotechnologyEspooFinland

Personalised recommendations